Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
a feature especially relevant in a compound intended to treat mainly elderly patients
also known as PTC124
2(3):197-201
allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas
Nitisinone is a remarkable safe drug to use with few side effects reported
Apilimod - CAS# 541550-19-0 ylic acid a feature especially relevant inApilimod, also known as STA 5326, is a IL 12 IL 23 inhibitor. Apilimod inhibits IL 12 and IL 23 production cytokines that are involved in autoimmune diseases through the prevention of nuclear translocation of c Rel. Synta Pharmaceuticals Corp is developing apilimod for the potential treatment of Crohn's disease (CD) and other autoimmune diseases. Preclinical studies demonstrated the successful inhibition of IL 12 and IL 23 production by the drug.